You are here:
Home
NICE Guidance
Conditions and diseases
Cancer
Metastases
Atezolizumab for adjuvant treatment of renal cell carcinoma with a high risk of metastasis [ID5101]
Discontinued
Reference number:
GID-TA11000
Project information
Project documents
12887-Atezolizumab-for-Renal-Cell-Carcinoma-V1.0-FEB2022-NON-CONF.pdf (nihr.ac.uk)
Back to top